Elevation of BACE in an Aβ rat model of Alzheimer's disease: Exacerbation by chronic stress and prevention by nicotine

International Journal of Neuropsychopharmacology

Volumn 15, Issue 2, 2012, Pages 223-233

  Alkadhi, Karim A ^a   Alzoubi, Karem H ^b   Srivareerat, Marisa ^a   Tran, Trinh T ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Alzheimer's rat model; APP; nicotinic acetylcholine receptor; psychosocial stress

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; NICOTINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DISEASE EXACERBATION; HIPPOCAMPAL CA1 REGION; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; MALE; NICOTINE; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL;

EID: 84857360110     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000162     Document Type: Article

References (96)

1. Aleisa AM, Alzoubi KH, Gerges NZ, Alkadhi KA (2006a). Chronic psychosocial stress-induced impairment of hippocampal LTP: possible role of BDNF. Neurobiology of Disease 22, 453-462. (Pubitemid 43832119)
2. Aleisa AM, Alzoubi KH, Gerges NZ, Alkadhi KA (2006b). Nicotine blocks stress-induced impairment of spatial memory and long-term potentiation of the hippocampal CA1 region. International Journal of Neuropsychopharmacology 9, 417-426. (Pubitemid 43979701)
3. Alkadhi KA, Alzoubi KH, Aleisa AM, Tanner FL, et al. (2005). Psychosocial stress-induced hypertension results from in vivo expression of long-term potentiation in rat sympathetic ganglia. Neurobiology of Disease 20, 849-857. (Pubitemid 41619360)
4. Alkadhi KA, Srivareerat M, Tran TT (2010). Intensification of long-term memory deficit by chronic stress and prevention by nicotine in a rat model of Alzheimer's disease. Molecular and Cellular Neuroscience 45, 289-296.
5. Alkadhi KA, Srivareerat M, Tran TT, Alzoubi KH (in press). Chronic psychosocial stress exacerbates impairment of synaptic plasticity in Ab-amyloid rat model of Alzheimer's disease: prevention by nicotine. Current Alzheimer's Research.
6. Alkondon M, Braga MF, Pereira EF, Maelicke A, et al. (2000). Alpha7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus. European Journal of Pharmacology 393, 59-67. (Pubitemid 30193401)
7. Alzoubi KH, Abdul-Razzak KK, Khabour OF, Al-Tuweiq GM, et al. (2009). Adverse effect of combination of chronic psychosocial stress and high fat diet on hippocampusdependent memory in rats. Behavioral Brain Research 204, 117-123.
8. Alzoubi KH, Gerges NZ, Alkadhi KA (2005). Levothyroxin restores hypothyroidism-induced impairment of LTP of hippocampal CA1: electrophysiological and molecular studies. Experimental Neurology 195, 330-341. (Pubitemid 41297786)
9. Bach ME, Hawkins RD, Osman M, Kandel ER, et al. (1995). Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency. Cell 81, 905-915.
10. Bales KR, Du Y, Dodel RC, Yan GM, et al. (1998). The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. Brain Research. Molecular Brain Research 57, 63-72. (Pubitemid 28279561)
11. Bales KR, Verina T, Cummins DJ, Du Y, et al. (1999). Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences USA 96, 15233-15238. (Pubitemid 30019795)
12. Barrow CJ, Zagorski MG (1991). Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179-182. (Pubitemid 21917135)
13. Bitan G, Vollers SS, Teplow DB (2003). Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. Journal of Biological Chemistry 278, 34882-34889. (Pubitemid 37102247)
14. Bodendorf U, Danner S, Fischer F, Stefani M, et al. (2002). Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid. Journal of Neurochemistry 80, 799-806. (Pubitemid 34809232)
15. Bourne KZ, Ferrari DC, Lange-Dohna C, Rossner S, et al. (2007). Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides. Journal of Neuroscience Research 85, 1194-1204. (Pubitemid 46724363)
16. Burdick D, Soreghan B, Kwon M, Kosmoski J, et al. (1992). Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. Journal of Biological Chemistry 267, 546-554.
17. Catania C, Sotiropoulos I, Silva R, Onofri C, et al. (2009). The amyloidogenic potential and behavioral correlates of stress. Molecular Psychiatry 14, 95-105.
18. Chen L, Yamada K, Nabeshima T, Sokabe M (2006). Alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats. Neuropharmacology 50, 254-268. (Pubitemid 43100011)
19. Chen QS, Kagan BL, Hirakura Y, Xie CW(2000). Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. Journal of Neuroscience Research 60, 65-72. (Pubitemid 30176750)
20. Chiti F, Dobson CM (2006). Protein misfolding, functional amyloid, and human disease. Annual Review of Biochemistry 75, 333-366. (Pubitemid 44118036)
21. Conrad CD, LeDoux JE, Magariñ os AM, McEwen BS (1999). Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behavioural Neuroscience 113, 902-913. (Pubitemid 30130866)
22. Dani JA, Heinemann S (1996). Molecular and cellular aspects of nicotine abuse. Neuron 16, 905-908. (Pubitemid 26171196)
23. Del Bo R, Angeretti N, Lucca E, De Simoni MG, et al. (1995). Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neuroscience Letters 188, 70-74.
24. Dineley KT, Bell KA, Bui D, Sweatt JD (2002). beta-amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. Journal of Biological Chemistry 277, 25056-25061. (Pubitemid 34951810)
25. Dineley KT, Westerman M, Bui D, Bell K, et al. (2001). Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. Journal of Neuroscience 21, 4125-4133. (Pubitemid 32538537)
26. Dougherty JJ, Wu J, Nichols RA (2003). Beta-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex. Journal of Neuroscience 23, 6740-6747. (Pubitemid 36951200)
27. Freir DB, Holscher C, Herron CE (2001). Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. Journal of Neurophysiology 85, 708-713. (Pubitemid 32147772)
28. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC (2002). Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Archives of Neurology 59, 1381-1389. (Pubitemid 35014802)
29. Gerges NZ, Aleisa AM, Schwarz LA, Alkadhi KA (2004a). Reduced basal CaMKII levels in hippocampal CA1 region: possible cause of stress-induced impairment of LTP in chronically stressed rats. Hippocampus 14, 402-410. (Pubitemid 38594413)
30. Gerges NZ, Alzoubi KH, Alkadhi KA (2005). Role of phosphorylated CaMKII and calcineurin in the differential effect of hypothyroidism on LTP of CA1 and dentate gyrus. Hippocampus 15, 480-490. (Pubitemid 40916295)
31. Gerges NZ, Alzoubi KH, Park CR, Diamond DM, et al. (2004b). Adverse effect of the combination of hypothyroidism and chronic psychosocial stress on hippocampus-dependent memory in rats. Behavioral Brain Research 155, 77-84. (Pubitemid 39119968)
32. Gerges NZ, Stringer JL, Alkadhi KA (2001). Combination of hypothyroidism and stress abolishes early LTP in the CA1 but not dentate gyrus of hippocampus of adult rats. Brain Research 922, 250-260. (Pubitemid 34017487)
33. Goldsbury C, Frey P, Olivieri V, Aebi U, et al. (2005). Multiple assembly pathways underlie amyloid-beta fibril polymorphisms. Journal of Molecular Biology 352, 282-298. (Pubitemid 41213315)
34. Green KN, Billings LM, Roozendaal B, McGaugh JL, et al. (2006). Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. Journal of Neuroscience 26, 9047-9056. (Pubitemid 44319396)
35. Hartlage-Rubsamen M, Zeitschel U, Apelt J, Gartner U, et al. (2003). Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent. Glia 41, 169-179. (Pubitemid 36262194)
36. Hellstrom-Lindahl E, Mousavi M, Zhang X, Ravid R, et al. (1999). Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Research. Molecular Brain Research 66, 94-103. (Pubitemid 29148337)
37. Hosur V, Leppanen S, Abutaha A, Loring RH (2009). Gene regulation of alpha4beta2 nicotinic receptors: microarray analysis of nicotine-induced receptor up-regulation and anti-inflammatory effects. Journal of Neurochemistry 111, 848-858.
38. Jin K, Peel AL, Mao XO, Xie L, et al. (2004). Increased hippocampal neurogenesis in Alzheimer's disease. Proceedings of the National Academy of Sciences USA 101, 343-347. (Pubitemid 38084252)
39. Jones IW, Westmacott A, Chan E, Jones RW, et al. (2006). Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes. Journal of Molecular Neuroscience 30, 83-84. (Pubitemid 46035331)
40. Kasa P, Rakonczay Z, Gulya K (1997). The cholinergic system in Alzheimer's disease. Progress in Neurobiology 52, 511-535. (Pubitemid 27405078)
41. Kotilinek LA, Bacskai B, Westerman M, Kawarabayashi T, et al. (2002). Reversible memory loss in a mouse transgenic model of Alzheimer's disease. Journal of Neuroscience 22, 6331-6335. (Pubitemid 35386387)
42. Lahiri DK, Utsuki T, Chen D, Farlow MR, et al. (2002). Nicotine reduces the secretion of Alzheimer's betaamyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins. Annals of the New York Academy of Science 965, 364-372. (Pubitemid 34721984)
43. Lee KW, Kim JB, Seo JS, Kim TK, et al. (2009). Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. Journal of Neurochemistry 108, 165-175.
44. Levin ED, Rezvani AH (2000). Development of nicotinic drug therapy for cognitive disorders. European Journal of Pharmacology 393, 141-146. (Pubitemid 30193410)
45. Lewczuk P, Wiltfang J (2008). Neurochemical dementia diagnostics: state of the art and research perspectives. Proteomics 8, 1292-1301. (Pubitemid 351462934)
46. Liu Q, Zhao B (2004). Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures. British Journal of Pharmacology 141, 746-754. (Pubitemid 38453267)
47. Lukas RJ (1991). Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line. Journal of Neurochemistry 56, 1134-1145. (Pubitemid 21902028)
48. Luo Y, Bolon B, Kahn S, Bennett BD, et al. (2001). Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nature Neuroscience 4, 231-232. (Pubitemid 32194866)
49. Mabley JG, Pacher P, Szabo C (2009). Activation of the cholinergic antiinflammatory pathway reduces ricin-induced mortality and organ failure in mice. Molecular Medicine 15, 166-172.
50. Mark RJ, Hensley K, Butterfield DA, Mattson MP (1995). Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. Journal of Neuroscience 15, 6239-6249.
51. Marrero MB, Bencherif M (2009). Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB. Brain Research 1256, 1-7.
52. Mattson MP (2004). Pathways towards and away from Alzheimer's disease. Nature 430, 631-639. (Pubitemid 39061671)
53. McEwen BS, Conrad CD, Kuroda Y, Frankfurt M, et al. (1997). Prevention of stress-induced morphological and cognitive consequences. European Neuropsychopharmacology 7 (Suppl. 3), S323-S328. (Pubitemid 27487897)
54. McGeer EG, McGeer PL (2003). Inflammatory processes in Alzheimer's disease. Progress in Neuropsychopharmacology and Biological Psychiatry 27, 741-749. (Pubitemid 36966754)
55. McGehee DS, Heath MJ, Gelber S, Devay P, et al. (1995). Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269, 1692-1696.
56. Molinari S, Battini R, Ferrari S, Pozzi L, et al. (1996). Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28 K expression. Proceedings of the National Academy of Sciences USA 93, 8028-8033.
57. Mugnaini M, Tessari M, Tarter G, Merlo Pich E, et al. (2002). Upregulation of [3H]methyllycaconitine binding sites following continuous infusion of nicotine, without changes of alpha7 or alpha6 subunit mRNA: an autoradiography and in situ hybridization study in rat brain. European Journal of Neuroscience 16, 1633-1646. (Pubitemid 35370695)
58. Nagele RG, D'Andrea MR, Anderson WJ, Wang HY (2002). Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110, 199-211. (Pubitemid 34214939)
59. Nitta A, Itoh A, Hasegawa T, Nabeshima T (1994). Betaamyloid protein-induced Alzheimer's disease animal model. Neuroscience Letters 170, 63-66.
60. Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, et al. (2009). Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. Journal of Immunology 183, 6681-6688.
61. Norman ED, Thiels E, Barrionuevo G, Klann E (2000). Long-term depression in the hippocampus in vivo is associated with protein phosphatase-dependent alterations in extracellular signal-regulated kinase. Journal of Neurochemistry 74, 192-198. (Pubitemid 30012769)
62. Park CR, Campbell AM, Diamond DM (2001). Chronic psychosocial stress impairs learning and memory and increases sensitivity to yohimbine in adult rats. Biological Psychiatry 50, 994-1004. (Pubitemid 34066492)
63. Parker SL, Fu Y, McAllen K, Luo J, et al. (2004). Upregulation of brain nicotinic acetylcholine receptors in the rat during long-term self-administration of nicotine: disproportionate increase of the alpha6 subunit. Molecular Pharmacology 65, 611-622. (Pubitemid 38264028)
64. Parpura-Gill A, Beitz D, Uemura E (1997). The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes. Brain Research 754, 65-71. (Pubitemid 27170252)
65. Pauly JR, Collins AC (1993). An autoradiographic analysis of alterations in nicotinic cholinergic receptors following 1 week of corticosterone supplementation. Neuroendocrinology 57, 262-271. (Pubitemid 23147807)
66. Paxinos G, Watson C (1986). The Rat Brain in Sterotaxic Coordinates, 2nd edn. New York: Academic Press Inc.
67. Peng X, Gerzanich V, Anand R, Whiting PJ, et al. (1994). Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Molecular Pharmacology 46, 523-530. (Pubitemid 24296687)
68. Perry E, Martin-Ruiz C, Lee M, Griffiths M, et al. (2000). Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. European Journal of Pharmacology 393, 215-222. (Pubitemid 30193419)
69. Pham E, Crews L, Ubhi K, Hansen L, et al. (2010). Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS Journal 277, 3051-3067.
70. Quik M, Philie J, Choremis J (1997). Modulation of alpha7 nicotinic receptor-mediated calcium influx by nicotinic agonists. Molecular Pharmacology 51, 499-506. (Pubitemid 27118487)
71. Roberds SL, Anderson J, Basi G, Bienkowski MJ, et al. (2001). BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Human Molecular Genetics 10, 1317-1324. (Pubitemid 32600485)
72. Rosas-Ballina M, Goldstein RS, Gallowitsch-Puerta M, Yang L, et al. (2009). The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Molecular Medicine 15, 195-202.
73. Sambamurti K, Kinsey R, Maloney B, Ge YW, et al. (2004). Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB Journal 18, 1034-1036. (Pubitemid 39561516)
74. Sandi C (2004). Stress, cognitive impairment and cell adhesion molecules. Nature Review Neuroscience 5, 917-930. (Pubitemid 39593355)
75. Seguela P, Wadiche J, Dineley-Miller K, Dani JA, et al. (1993). Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. Journal of Neuroscience 13, 596-604. (Pubitemid 23045143)
76. Shimohama S, Kihara T (2001). Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity. Biological Psychiatry 49, 233-239. (Pubitemid 32178432)
77. Son H, Madelian V, Carpenter DO (1996). The translocation and involvement of protein kinase C in mossy fiber-CA3 long-term potentiation in hippocampus of the rat brain. Brain Research 739, 282-292. (Pubitemid 26387387)
78. Spies PE, Slats D, Sjogren JM, Kremer BP, et al. (2010). The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia. Current Alzheimer Research 7, 470-476.
79. Srivareerat M, Tran TT, Alzoubi KH, Alkadhi KA (2009a). Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease. Biological Psychiatry 65, 918-926.
80. Srivareerat M, Tran TT, Salim S, Aleisa AM, et al. (2009b). Chronic nicotine restores normal Abeta levels and prevents short-term memory and E-LTP impairment in Abeta rat model of Alzheimer's disease. Neurobiology of Aging. Published online: 25 May 2009. doi:10.1016/j.neurobiolaging.2009.04.015.
81. Stravalaci M, Beeg M, Salmona M, Gobbi M (2011). Use of surface plasmon resonance to study the elongation kinetics and the binding properties of the highly amyloidogenic Abeta(1-42) peptide, synthesized by depsi-peptide technique. Biosensors and Bioelectronics. 26, 2772-2775.
82. Sze CI, Troncoso JC, Kawas C, Mouton P, et al. (1997). Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 56, 933-944. (Pubitemid 27329114)
83. Takita M, Taniguchi T, Zhu J, Piao HL, et al. (1999). Effects of chronic treatment with (+)-nicotine on the stress-induced hypertension and downregulation of central nicotinic receptors in rats: comparative study with (-)-nicotine. General Pharmacology 33, 29-33. (Pubitemid 29292429)
84. Terry RD, Masliah E, Salmon DP, Butters N, et al. (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology 30, 572-580.
85. Tran TT, Srivareerat M, Alkadhi KA (2010a). Chronic psychosocial stress accelerates impairment of long-term memory and late-phase long-term potentiation in an at-risk model of Alzheimer's disease. Hippocampus. Published online: 13 April 2010. doi:10.1002/hipo.20790.
86. Tran TT, Srivareerat M, Alkadhi KA (2010b). Chronic psychosocial stress triggers cognitive impairment in a novel at-risk model of Alzheimer's disease. Neurobiology of Disease 37, 756-763.
87. Utsuki T, Shoaib M, Holloway HW, Ingram DK, et al. (2002). Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat. Journal of Alzheimer's Disease 4, 405-415. (Pubitemid 35397806)
88. Vassar R, Bennett BD, Babu-Khan S, Kahn S, et al. (1999). Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
89. Vassar R, Kovacs DM, Yan R, Wong PC (2009). The betasecretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. Journal of Neuroscience 29, 12787-12794.
90. Wang HY, Lee DH, Davis CB, Shank RP (2000a). Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. Journal of Neurochemistry 75, 1155-1161. (Pubitemid 30660505)
91. Wang HY, Lee DH, D'Andrea MR, Peterson PA, et al. (2000b). beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. Journal of Biological Chemistry 275, 5626-5632. (Pubitemid 30115201)
92. Wiberg H, Ek P, Pettersson FE, Lannfelt L, et al. (2010). Separation and characterization of aggregated species of amyloid-beta peptides. Analytical and Bioanalytical Chemistry 397, 2357-2366.
93. Wonnacott S (1990). The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends in Pharmacological Science 11, 216-219. (Pubitemid 20175409)
94. Yildiz D (2004). Nicotine, its metabolism and an overview of its biological effects. Toxicon 43, 619-632. (Pubitemid 38520766)
95. Yun J, Koike H, Ibi D, Toth E, et al. (2010). Chronic restraint stress impairs neurogenesis and hippocampus-dependent fear memory in mice: possible involvement of a brainspecific transcription factor Npas4. Journal of Neurochemistry 114, 1840-1851.
96. Zuccato C, Cattaneo E (2009). Brain-derived neurotrophic factor in neurodegenerative diseases. Nature Reviews Neurology 5, 311-322.